ESR1 and migraine disorder: Migraine was not associated with ER+/PR+ invasive cancer in either study (combined-analysis adjusted HR = 1.03 (0.86, 1.23) for nonmenstrually-related migraine, HR = 1.04 (0.86, 1.27) for menstrually-related migraine) (Table 2).